Home

Richard E. Lowenthal, President and CEO: ARS Pharmaceuticals SPRY Planned sale · Filed 08/20

Trade details

Type
Planned sale notice
Planned sale date
26/08/20
Filed
26/08/20

More to sell after $638.2K in 3 months

ARS Pharmaceuticals trades, last 26 weeks

What else happened in ARS Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 07/21~09/19

Richard E. Lowenthal's recent trades

  • Richard E. Lowenthal

    Planned saleARS Pharmaceuticals

    $177K

    Filed 09/11

  • Richard E. Lowenthal

    Planned saleARS Pharmaceuticals

    $421.1K

    Filed 09/04

  • Richard E. Lowenthal

    Planned saleARS Pharmaceuticals

    $115.6K

    Filed 09/03

  • Richard E. Lowenthal

    Planned saleARS Pharmaceuticals

    $5,000

    Filed 09/02

  • Richard E. Lowenthal

    Planned saleARS Pharmaceuticals

    $322.3K

    Filed 08/19